Prescription Drugs
  • Mircera is an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia associated with chronic kidney disease (CKD in adult patients on dialysis and patients not on dialysis
  • Primary hypercholesterolemia: As an adjuvant to diet to reduce elevated total-cholesterol, LDL-cholesterol, apolipoprotein-B, triglycerides and non-HDL-cholesterol, and to increase HDL-cholesterol in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) or mixed dyslipidemia
  • Active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra is approved for use in individuals 9 months through 55 years of age
  • Combination with lenalidomide in adult patients with relapsed or refractory diffuse large B-cell lymphoma(DLBCL) who are not eligible for autologous stem cell transplant(ASCT) and failed one or more prior therapies, followed by this drug monotherapy.
    Oncology
  • Treatment of hypertension, stable angina pectoris
  • Treatment of painful myospasm accompanying musculoskeletal diseases: cervicoomobrachial syndrome, periarthritis, back pain
맨위로